v3.22.2.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 266,126 $ 316,827
Marketable securities, at fair value 177,414 198,563
Accounts receivable, net 111,994 112,130
Inventories 23,799 23,395
Prepaid assets 16,511 12,354
Assets held for sale 0 10,050
Other current assets 7,516 8,189
Total current assets 603,360 681,508
Property and equipment (net of accumulated depreciation of $125,018 and $109,952, respectively) 106,818 109,465
Operating lease right-of-use assets 98,945 102,197
Intangible assets, net 416,848 442,325
Goodwill 522,766 527,115
Other assets 6,845 7,168
Total non-current assets 1,152,222 1,188,270
Total assets 1,755,582 1,869,778
Current liabilities    
Accounts payable 13,708 17,921
Accrued compensation 37,992 38,304
Accrued expenses and other liabilities 20,420 17,796
Current portion of equipment financing obligations 118 1,135
Current portion of operating lease liabilities 6,379 6,884
Pharma contract liabilities 6,386 5,192
Total current liabilities 85,003 87,232
Long-term liabilities    
Convertible senior notes, net 534,609 532,483
Operating lease liabilities 70,471 72,289
Deferred income tax liabilities, net 38,345 55,475
Other long-term liabilities 14,166 14,022
Total long-term liabilities 657,591 674,269
Total liabilities 742,594 761,501
Commitments and contingencies (Note 11)
Stockholders’ equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 126,562,037 and 124,107,500 shares issued and outstanding, respectively) 127 124
Additional paid-in capital 1,154,365 1,123,628
Accumulated other comprehensive loss (5,104) (638)
Accumulated deficit (136,400) (14,837)
Total stockholders’ equity 1,012,988 1,108,277
Total liabilities and stockholders’ equity $ 1,755,582 $ 1,869,778

Source